MoneyWorks4Me

Solara Active Pharma Sciences incorporates wholly-owned subsidiary

30 Apr 2025 Evaluate

Solara Active Pharma Sciences has incorporated wholly-owned subsidiary in the name of ‘Synthix Global Pharma Solutions’ is on April 29, 2025. The wholly- owned subsidiary is being incorporated in relation to proposed demerger of the CRAMS and polymers business into an independent entity.  

Solara Active Pharma Sciences is a dynamic, entrepreneurial and customer-oriented API manufacturer. 


Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..